SCHEMBL22459266

SCHEMBL22459266

C=C(COC)C(=O)OCCOc1ccc(-c2ccc(-c3ccc(OCCOC(=O)C(=C)COC)cc3)c(F)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 2/20 0.43
▸ RARA P10276 1/20 0.43
▸ FFAR1 O14842 4/20 0.38
▸ FFAR4 Q5NUL3 4/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ APP P05067 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PTGES O14684 1/20 0.36
▸ CTSA P10619 1/20 0.35
▸ RARG P13631 1/20 0.35
▸ PRKAB2 O43741 1/20 0.35
▸ PRKAG1 P54619 1/20 0.35
▸ PRKAA2 P54646 1/20 0.35
▸ PRKAA1 Q13131 1/20 0.35
▸ PRKAG3 Q9UGI9 1/20 0.35
▸ PRKAG2 Q9UGJ0 1/20 0.35
▸ PRKAB1 Q9Y478 1/20 0.35
▸ S1PR1 P21453 2/20 0.35
▸ S1PR3 Q99500 2/20 0.35
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459796 1.00 RARB (0.43) RARBRARAFFAR1FFAR4CHEK2
SCHEMBL22459777 0.93 RARB (0.43) RARBRARAFFAR1FFAR4CHEK2
SCHEMBL22459560 0.93 THRB (0.44) RARBRARAFFAR1FFAR4CHEK2
SCHEMBL22459724 0.92 FFAR1 (0.36) RARBRARAFFAR1FFAR4CHEK2
SCHEMBL22459376 0.90 POLB (0.42) RARBRARAFFAR1FFAR4CHEK2
SCHEMBL22561054 0.89 RARA (0.36) RARBRARAFFAR1FFAR4CHEK2
SCHEMBL22459238 0.89 S1PR1 (0.38) RARBRARAFFAR1FFAR4CHEK2
SCHEMBL21422426 0.89 RARB (0.43) RARBRARAFFAR1S1PR1
SCHEMBL22459323 0.89 RARB (0.43) RARBRARAPOLBAPEX1HTT
SCHEMBL22459248 0.87 POLB (0.43) RARBCHEK2POLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725764-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2020-10-21 — — EP disclosed
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 RARB 3668/4885RARA 3532/4885FFAR1 1593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback